147 related articles for article (PubMed ID: 13755873)
1. Treatment of geriatric patients with etryptamine acetate.
KIESSLING AJ
J Neuropsychiatr; 1961 Feb; 2(Suppl1)():64-5. PubMed ID: 13755873
[No Abstract] [Full Text] [Related]
2. Depression--its treatment with etryptamine acetate.
SETTEL E
J Am Geriatr Soc; 1961 Sep; 9():755-8. PubMed ID: 13750393
[No Abstract] [Full Text] [Related]
3. Etryptamine acetate in general practice.
CHOGICH JC
J Neuropsychiatr; 1961; 3():96-7. PubMed ID: 13879126
[No Abstract] [Full Text] [Related]
4. Alpha-ethyltryptamine acetate in the treatment of depression, a study of the methodology of drug evaluation.
KAST EC
J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():114-8. PubMed ID: 13751710
[No Abstract] [Full Text] [Related]
5. Clinical experiences with etryptamine in office practice.
MALETZ L
J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():58-60. PubMed ID: 13765760
[No Abstract] [Full Text] [Related]
6. Etryptamine, a new and safer antidepressant chemical.
ROBIE TR
Dis Nerv Syst; 1961 Aug; 22():452-6. PubMed ID: 13742241
[No Abstract] [Full Text] [Related]
7. Alpha-ethyltryptamine acetate in alcoholism. A preliminary report.
LAWRENCE FE
J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():88-90. PubMed ID: 13759684
[No Abstract] [Full Text] [Related]
8. [Clinical-psychiatric experiences with ethyl tryptamine acetate].
FISCHER PA
Arztl Forsch; 1962 Aug; 16():I/429-31. PubMed ID: 13893160
[No Abstract] [Full Text] [Related]
9. A monoamine oxidase inhibitor in the treatment of organic disease.
MUETHER RO; SCHUETZ A; DEL ROSARIO H; SOMMER AJ
J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():80-5. PubMed ID: 13773597
[No Abstract] [Full Text] [Related]
10. In vivo metabolism of serotonin and tryptamine: effect of monoamine oxidase inhibition.
WEISSBACH H; LOVENBERG W; REDFIELD BG; UDENFRIEND S
J Pharmacol Exp Ther; 1961 Jan; 131():26-30. PubMed ID: 13784114
[No Abstract] [Full Text] [Related]
11. Clinical studies with ethyltryptamine.
TURNER WJ; MERLIS S
J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():73-6. PubMed ID: 13778759
[No Abstract] [Full Text] [Related]
12. Antidepressant medication and its use in psychiatric hospital practice.
TURNER WJ; MERLIS S
J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():69-72. PubMed ID: 13778758
[No Abstract] [Full Text] [Related]
13. The effect of monoamine oxidase inhibitors and tryptophan on the tryptamine content of animal tissues and urine.
HESS SM; REDFIELD BG; UDENFRIEND S
J Pharmacol Exp Ther; 1959 Nov; 127():178-81. PubMed ID: 14401504
[No Abstract] [Full Text] [Related]
14. [On monoamine-oxidase inhibitors].
KROEBER E
Psychiatr Neurol (Basel); 1960 Jul; 140():92-6. PubMed ID: 13754442
[No Abstract] [Full Text] [Related]
15. Etryptamine acetate--a new antidepressant chemical.
ROBIE TR
J Neuropsychiatr; 1962; 3():181-5. PubMed ID: 14492850
[No Abstract] [Full Text] [Related]
16. Neuropharmacological studies on dl-alpha-ethyltryptamine acetate.
MATTHEWS RJ; ROBERTS BJ; ADKINS PK
J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():151-8. PubMed ID: 13768295
[No Abstract] [Full Text] [Related]
17. [Our experiences with monoamine oxidase inhibiting substances].
TAUBER CG
Psychiatr Neurol (Basel); 1960 Jul; 140():148-51. PubMed ID: 13775480
[No Abstract] [Full Text] [Related]
18. A new and safer monoamine oxidase inhibitor.
ROBIE TR
J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():31-48. PubMed ID: 13742239
[No Abstract] [Full Text] [Related]
19. Etryptamine acetate--its use in gastrointestinal disease.
HOCK CW
J Neuropsychiatr; 1961 Feb; 2(Suppl 1)():102-3. PubMed ID: 13714807
[No Abstract] [Full Text] [Related]
20. Memory function of patients taking etryptamine acetate.
BYLENGA ND; MAY RH
J Nerv Ment Dis; 1961 Sep; 133():213-5. PubMed ID: 13875315
[No Abstract] [Full Text] [Related]
[Next] [New Search]
